This appointment is especially troubling given the President’s signing statement indicating that he plans to resist the oversight procedures in the CARES Act, which were overwhelmingly agreed to on a bipartisan basis to prevent corporate misconduct and abuse.— James E. Clyburn (@WhipClyburn) April 4, 2020